Myriad Genetics, Inc. (MYGN)

pos +0.00
Today's Range: 26.01 - 26.42 | MYGN Avg Daily Volume: 0
Last Update: 06/23/17 - 4:00 PM EDT
Volume: 0
YTD Performance: 0.00%
Open: $0.00
Previous Close: $26.26
52 Week Range: $15.15 - $32.97
Oustanding Shares: 68,118,000,000
Market Cap: 1,788,449,900
6-Month Chart
TheStreet Ratings Grade for MYGN
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy
Moderate Buy
Moderate Sell
Strong Sell
Mean Rec. 0.00 0.00 0.00 0.00
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 0.00
Price Earnings Comparisons:
MYGN Sector Avg. S&P 500
0.00 0.00 0.00
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
0.00% 0.00% 0.00%
Revenue 0.00 0.00 0.00
Net Income 0.00 0.00 0.00
EPS 0.00 0.00 0.00
Earnings for MYGN:
Revenue 0.00B
Average Earnings Estimates
Qtr (06/17) Qtr (09/17) FY (06/17) FY (06/18)
Average Estimate $0.26 $0.24 $1.02 $1.06
Number of Analysts 8 6 10 11
High Estimate $0.27 $0.27 $1.05 $1.30
Low Estimate $0.23 $0.20 $0.99 $0.85
Prior Year $0.36 $0.23 $1.63 $1.02
Growth Rate (Year over Year) -27.08% 4.35% -37.55% 4.13%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
Finding the stocks that have changed direction.
Those who thought we were ready to break down look foolish again.
All the long-term indicators are aligned for declines.
I'm not inclined to make market calls, but the action on my screen is pushing me to a defensive stance.
Aug 10, 2016 | 7:45 AM EDT
MYGN was downgraded from Overweight to Equal-weight, Barclays said. $24 price target. Company is losing market share faster than expect...
Aug 10, 2016 | 7:23 AM EDT
MYGN was downgraded from Overweight to Neutral, Piper Jaffray said. $22 price target. Company is losing market share in hereditary canc...
Jul 29, 2016 | 7:52 AM EDT
MYGN was downgraded from Neutral to Underperform, Bank of America/Merrill Lynch said. $25 price target. Pricing pressures will begin to...
The stock still maintains a bullish slant on the daily chart.
Aug 25, 2015 | 7:11 AM EDT
MYGN was upgraded from Market Perform to Outperform, Wells Fargo said. Recent meeting with management confirms a better business outloo...
Feb 04, 2015 | 7:51 AM EST
MYGN was downgraded from Neutral to Underperform, Credit Suisse said. $30 price target. Estimates also cut, given the company's new gui...

Columnist Conversations

we still like this trade but need some more time on it. SOLD WDC JUL 87.5 CALL AT 5.40 (in at 5.85) BOUG...
Impinj ( $PI) is still forming a bull flag. Holding up just fine, and 27% of float is short. This is a powe...
stellar numbers and the stock continues to attract buyers, it's now in the fat tail and this could go for a fe...
General Electric's outgoing CEO Jeff Immelt had some choice things to say at an event in NYC on Thursday ...


News Breaks

Powered by


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.